TipRanks
Advertisement
Advertisement

DE:4YB Stock Latest News

Wainwright maintains confidence in Immunovant’s pipeline despite CLE setback
The FlyWainwright maintains confidence in Immunovant’s pipeline despite CLE setback
14d ago
IMVT
ROIV
Roivant Sciences price target raised to $41 from $37.50 at BofA
PremiumThe Fly
Roivant Sciences price target raised to $41 from $37.50 at BofA
14d ago
IMVT
ROIV
Immunovant announces IMVT-1402 study did not achieve statistical significance
PremiumThe Fly
Immunovant announces IMVT-1402 study did not achieve statistical significance
14d ago
IMVT
Immunovant Shareholders Back Board, Auditor and Executive Pay
PremiumCompany Announcements
Immunovant Shareholders Back Board, Auditor and Executive Pay
1M ago
8K
IMVT
Immunovant Earnings Call: Cash Windfall and Key Catalysts
PremiumCompany Announcements
Immunovant Earnings Call: Cash Windfall and Key Catalysts
2M ago
IMVT
Immunovant price target raised to $45 from $43 at BofA
PremiumThe FlyImmunovant price target raised to $45 from $43 at BofA
2M ago
IMVT
Immunovant Reaffirmed at Buy as IMVT-1402 Trials Advance; $53 Price Target Maintained
Premium
Ratings
Immunovant Reaffirmed at Buy as IMVT-1402 Trials Advance; $53 Price Target Maintained
2M ago
IMVT
Immunovant reports Q2 EPS (75c), consensus (61c)
Premium
The Fly
Immunovant reports Q2 EPS (75c), consensus (61c)
2M ago
IMVT
Immunovant price target raised to $50 from $47 at JPMorgan
PremiumThe Fly
Immunovant price target raised to $50 from $47 at JPMorgan
2M ago
IMVT
Immunovant price target raised to $61 from $57 at Citi
PremiumThe Fly
Immunovant price target raised to $61 from $57 at Citi
3M ago
IMVT
Immunovant price target raised to $47 from $35 at JPMorgan
PremiumThe Fly
Immunovant price target raised to $47 from $35 at JPMorgan
4M ago
IMVT
Immunovant price target raised to $62 from $44 at Guggenheim
PremiumThe Fly
Immunovant price target raised to $62 from $44 at Guggenheim
4M ago
IMVT
Immunovant price target raised to $30 from $23 at Truist
PremiumThe FlyImmunovant price target raised to $30 from $23 at Truist
5M ago
IMVT
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
Premium
Company Announcements
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
5M ago
IMVT
Immunovant price target raised to $43 from $32 at BofA
Premium
The Fly
Immunovant price target raised to $43 from $32 at BofA
5M ago
IMVT
Immunovant price target raised to $40 from $35 at H.C. Wainwright
PremiumThe Fly
Immunovant price target raised to $40 from $35 at H.C. Wainwright
5M ago
IMVT
Immunovant rises 33.6%
PremiumThe Fly
Immunovant rises 33.6%
5M ago
IMVT
Immunovant rises 25.9%
PremiumThe Fly
Immunovant rises 25.9%
5M ago
IMVT
Immunovant reports Q4 EPS (73c), consensus (63)
PremiumThe Fly
Immunovant reports Q4 EPS (73c), consensus (63)
5M ago
IMVT
Immunovant price target raised to $32 from $29 at Goldman Sachs
PremiumThe FlyImmunovant price target raised to $32 from $29 at Goldman Sachs
6M ago
IMVT
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
Premium
Ratings
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
6M ago
IMVT
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
Premium
The Fly
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
6M ago
F
BP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >